Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States.
Saved in:
| Title: | Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States. |
|---|---|
| Authors: | Gordan LN; Florida Cancer Specialists & Research Institute, Gainesville, FL, USA., Bensimon AG; Analysis Group, Inc, Boston, MA, USA., Mu F; Analysis Group, Inc, Boston, MA, USA., Kim N; Johnson & Johnson, Horsham, PA, USA., Wu B; Johnson & Johnson, Horsham, PA, USA., Lin D; Johnson & Johnson, Horsham, PA, USA., Paner A; Johnson & Johnson, Horsham, PA, USA., Fowler J; Johnson & Johnson, Horsham, PA, USA., Marshall A; Johnson & Johnson, LLC, Raritan, NJ, USA., Van Sanden S; Johnson & Johnson NV, Beerse, Belgium., Ammann E; Johnson & Johnson, LLC, Raritan, NJ, USA., Goble J; Johnson & Johnson, Horsham, PA, USA., Zhang X; Johnson & Johnson, Horsham, PA, USA., Le HH; Johnson & Johnson, Horsham, PA, USA., Min EE; Johnson & Johnson, Horsham, PA, USA.; Purdue University College of Pharmacy, West Lafayette, IN, USA., Garrison LP Jr; University of Washington, School of Pharmacy, Seattle, WA, USA. |
| Source: | Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 910-920. Date of Electronic Publication: 2025 Jun 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40495704 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gordan+LN%22">Gordan LN</searchLink>; Florida Cancer Specialists & Research Institute, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Bensimon+AG%22">Bensimon AG</searchLink>; Analysis Group, Inc, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mu+F%22">Mu F</searchLink>; Analysis Group, Inc, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+N%22">Kim N</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+D%22">Lin D</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Paner+A%22">Paner A</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+J%22">Fowler J</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Marshall+A%22">Marshall A</searchLink>; Johnson & Johnson, LLC, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Van+Sanden+S%22">Van Sanden S</searchLink>; Johnson & Johnson NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Ammann+E%22">Ammann E</searchLink>; Johnson & Johnson, LLC, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Goble+J%22">Goble J</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Le+HH%22">Le HH</searchLink>; Johnson & Johnson, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Min+EE%22">Min EE</searchLink>; Johnson & Johnson, Horsham, PA, USA.; Purdue University College of Pharmacy, West Lafayette, IN, USA.<br /><searchLink fieldCode="AU" term="%22Garrison+LP+Jr%22">Garrison LP Jr</searchLink>; University of Washington, School of Pharmacy, Seattle, WA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229892255%22">Journal of medical economics</searchLink> [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 910-920. <i>Date of Electronic Publication: </i>2025 Jun 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9892255 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1941-837X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213696998%22">13696998 </searchLink><i>NLM ISO Abbreviation: </i>J Med Econ <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40495704 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13696998.2025.2514909 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 910 Titles: – TitleFull: Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gordan LN – PersonEntity: Name: NameFull: Bensimon AG – PersonEntity: Name: NameFull: Mu F – PersonEntity: Name: NameFull: Kim N – PersonEntity: Name: NameFull: Wu B – PersonEntity: Name: NameFull: Lin D – PersonEntity: Name: NameFull: Paner A – PersonEntity: Name: NameFull: Fowler J – PersonEntity: Name: NameFull: Marshall A – PersonEntity: Name: NameFull: Van Sanden S – PersonEntity: Name: NameFull: Ammann E – PersonEntity: Name: NameFull: Goble J – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Le HH – PersonEntity: Name: NameFull: Min EE – PersonEntity: Name: NameFull: Garrison LP Jr IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1941-837X Numbering: – Type: volume Value: 28 – Type: issue Value: 1 Titles: – TitleFull: Journal of medical economics Type: main |
| ResultId | 1 |